Big Movers In Diagnostics Today: Immucor (BLUD) Up 6.5% and Cepheid (CPHD) up 12%
Good financials have perked up interest is mid-cap Diagnostics companies that released results today. Immucor (BLUD) a global leader in automated analysis of blood transfusion systems had revenue of $82.9M up 5% from prior year quarter with diluted earnings of $0.30 per share compared to $0.27 in the prior year quarter.Cash Flow from operations was [...]
